Tetragon Financial Management LP 13D and 13G filings for Autolus Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-31 4:10 pm Sale | 2023-12-31 | 13G | Autolus Therapeutics plc AUTL | Tetragon Financial Management LP | 8,000,000 4.600% | -1,461,883 (-15.45%) | Filing |
| 2023-03-20 09:13 am Purchase | 2023-03-09 | 13G | Autolus Therapeutics plc AUTL | Tetragon Financial Management LP | 9,461,883 5.500% | 9,461,883 (New Position) | Filing |